*ST长药：8月22日召开董事会会议

Group 1 - The core point of the article is that *ST Changyao announced a board meeting to address accounting errors in the first quarter financial report for 2025 [1] - For the first half of 2025, *ST Changyao's revenue composition is 68.0% from the photovoltaic industry and 32.0% from the pharmaceutical industry [1] - As of the report, *ST Changyao has a market capitalization of 1.5 billion yuan [1]